Novartis AG
Patents, Design & Utilities
Last updated:
List of all Novartis AG patents 1,223 in total
| Status | Patent |
|---|---|
Grant | Utility: Triazolopyrimidine compounds and uses thereof Filling date: 23 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Chemical process for preparing phenylpiperidinyl indole derivatives Filling date: 23 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Illuminated ophthalmic infusion line and associated devices, systems, and methods Filling date: 23 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Pharmaceutical composition Filling date: 23 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Cell culture medium Filling date: 23 Sep 2025 Issue date: 28 Dec 2021 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS OF LIPOIC ACID CHOLINE ESTER SALTS AND METHODS OF TREATMENT USING SAME Filling date: 23 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: APPLICATION UNLOCK USING A CONNECTED PHYSICAL DEVICE AND TRANSFER OF DATA THEREBETWEEN Filling date: 23 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: METHYL (R)-2-(FLUOROMETHYL)-5-OXO-4-PHENYL-4,5,6,7-TETRAHYDRO-1H-CYCLOPENT- A[B]PYRIDINE-3-CARBOXYLATE AND METHYL (R)-2-(FLUOROMETHYL)-5-OXO-4-PHENYL-1,4,5,7-TETRAHYDROFURO[3,4-B]PYRIDINE- -3-CARBOXYLATE AS CAV1.2 ACTIVATORS Filling date: 23 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: METHOD FOR REDUCING THE RISK OF A CARDIOVASCULAR EVENT WITH CONJUGATED ANTISENSE COMPOUNDS TARGETING APO(A) Filling date: 23 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: NLRP MODULATORS Filling date: 23 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: BIOMARKERS FOR EVALUATING CAR-T CELLS TO PREDICT CLINICAL OUTCOME Filling date: 23 Sep 2025 Issue date: 23 Dec 2021 |
Grant | Utility: Aza-indazole compounds for use in tendon and/or ligament injuries Filling date: 23 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Eukaryotic cells and methods for recombinantly expressing a product of interest Filling date: 23 Sep 2025 Issue date: 21 Dec 2021 |
Application | Utility: Nucleic Acids Encoding FGF21-Fc Fusion Proteins Filling date: 23 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: METHODS FOR TREATING LIVER DISORDERS USING FXR AGONISTS Filling date: 23 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: METHYL 2-METHYL-5-OXO-1,4,5,7-TETRADHYDROFURO[3,4-b]PYRIDINE-3-CARBOXYLATE COMPOUNDS AS CAV1.2 ACTIVATORS Filling date: 23 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE Filling date: 23 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: PHARMACEUTICAL COMBINATIONS Filling date: 23 Sep 2025 Issue date: 16 Dec 2021 |
Grant | Utility: Oil-in-water emulsions including retinoic acid Filling date: 23 Sep 2025 Issue date: 14 Dec 2021 |
Application | Utility: The use of a H3R inverse agonist for the treatment of excessive daytime sleepiness associated with parkinson's disease (PD) Filling date: 23 Sep 2025 Issue date: 9 Dec 2021 |
Grant | Utility: 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Filling date: 23 Sep 2025 Issue date: 7 Dec 2021 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES Filling date: 23 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSIDS AND METHODS OF USE THEREOF Filling date: 23 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: CRYSTALLINE FORM OF LNP023 Filling date: 23 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: Use of IL-1 beta Binding Antibodies Filling date: 23 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 Filling date: 23 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: COVALENT TARGETING OF E3 LIGASES Filling date: 23 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: USE OF CANAKINUMAB Filling date: 23 Sep 2025 Issue date: 2 Dec 2021 |
Grant | Utility: Syringe Filling date: 23 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Filling date: 23 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: Surgical microscope with integrated optical coherence tomography and display systems Filling date: 23 Sep 2025 Issue date: 30 Nov 2021 |
Application | Utility: MYOSTATIN, ACTIVIN OR ACTIVIN RECEPTOR ANTAGONISTS FOR USE IN TREATING OBESITY AND RELATED CONDITIONS Filling date: 23 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: PHARMACEUTICAL COMBINATIONS Filling date: 23 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: FXR AGONISTS FOR THE TREATMENT OF LIVER DISEASES Filling date: 23 Sep 2025 Issue date: 25 Nov 2021 |
Grant | Utility: Syringe Filling date: 23 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Design: Display screen with graphical user interface Filling date: 23 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Amino pyrimidine derivatives Filling date: 23 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Peptides and compositions for treatment of joint damage Filling date: 23 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Pharmaceutical combination comprising LSZ102 and ribociclib Filling date: 23 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Licofligozin for the treatment of non-alcoholic steatohepatitis Filling date: 23 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Methods of treatment of cancer with reduced UBB expression Filling date: 23 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: TGFbeta 2 antibodies Filling date: 23 Sep 2025 Issue date: 23 Nov 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO Filling date: 23 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: CYCLODEXTRIN-BASED FORMULATION OF A BCL-2 INHIBITOR Filling date: 23 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: ISOXAZOLE CARBOXAMIDE COMPOUNDS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: MANUFACTURE OF COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 Filling date: 23 Sep 2025 Issue date: 18 Nov 2021 |
Grant | Utility: Expression vector system comprising two selection markers Filling date: 23 Sep 2025 Issue date: 16 Nov 2021 |
Grant | Utility: Illuminated ophthalmic cannula Filling date: 23 Sep 2025 Issue date: 16 Nov 2021 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR INDUCING CHONDROGENESIS Filling date: 23 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST Filling date: 23 Sep 2025 Issue date: 11 Nov 2021 |
Showing 200 to 250 of 1223 patents.